Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Iron deficiency anemia indicates poor nutrition and is a public health problem. Iron deficiency is also associated with muscle weakness. However, the intracellular mechanisms by which iron deficiency induces muscle weakness are obscure. The purpose of the present study was to evaluate the effect of iron deficiency on protein synthesis in basal and branched-amino acids (BCAA)- and insulin-stimulated state in muscle cells. Differentiated C2C12 myotubes were incubated with an
iron
chelator, deferoxamine mesylate, and then stimulated with BCAA or insulin to activate protein synthesis. This
iron
deprivation resulted in a significant reduction in the abundance of
iron
-containing proteins, such as the mitochondrial complex 1 subunit protein, compared to control cells, but not of protein that does not contain
iron
, such as
citrate synthase
. Proteins involved in glucose utilization, such as glucose transpoter-1, hexokinase and AMP-activated protein kinase (AMPK), were upregulated under iron deficiency. Additionally, rates of BCAA- and insulin-stimulated protein synthesis, measured by puromycin incorporation, were lower in
iron
-deficient myotubes than in control cells. We suggest that low
iron
availability attenuates BCAA- and insulin-stimulated protein synthesis, possibly via activation of AMPK in myotubes. The present findings advance the understanding of the importance of
iron
to skeletal muscle protein synthesis and, thus, may contribute to the prevention of sarcopenia and frailty.
...
PMID:Iron deficiency attenuates protein synthesis stimulated by branched-chain amino acids and insulin in myotubes. 3278 44
<< Previous
1
2
3
4
5
6